Myricx Pharma
Seedtable Score
44
Startups
1
Funding Rounds
1
Investors
$6.02m
Money raised
Overview
Myricx Pharma, based in London, operates a drug discovery platform specializing in small molecule inhibitors for specific diseases. By focusing on targeted treatments, Myricx has carved a niche in the pharmaceutical landscape. This B2B model allows for collaboration with major pharma firms, potentially increasing market reach and innovation. With investment backing from Sofinnova Partners, the company is financially well-positioned. However, their focus on small molecule inhibitors may slow drug development and risk missing novel treatment opportunities. Despite this, Myricx's expertise distinguishes it from competitors using conventional drug discovery methods.
- Website: https://myricxpharma.com
- Business model: b2b
- Company size: 1 - 11 employees
- Headquarters: London, UK
- Founded: 2019
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (1)
Sofinnova Partners
Healthcare, Manufacturing, Health Tech, Synthetic biology, Technology, ...
DetailsFunding
Funding series
Funding Series Analysis
The company Myricx Pharma has raised a total of $6.02m in funding over 1 rounds.
Key Insights:
- Seed: $6.02m
Myricx Pharma Seed (2020, $6M)
$6.02m